(Q43931045)

28 November 2017

title

Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis (English)

1 reference

28 November 2017

0 references

cognitive dysfunction

1 reference

2

1 reference

28 November 2017

Christoph Heesen

1

1 reference

28 November 2017

Alaleh Raji

series ordinal

3

1 reference

28 November 2017

Klaus Wiedemann

series ordinal

4

1 reference

28 November 2017

Karl-Heinz Schulz

series ordinal

5

1 reference

28 November 2017

publication date

1 May 2002

1 reference

28 November 2017

published in

Psychoneuroendocrinology

1 reference

28 November 2017

volume

27

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

505-517

1 reference

The effects of the anti-glucocorticoid RU 38486 on steroid-mediated suppression of experimental allergic encephalomyelitis (EAE) in the Lewis rat

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Speed of information processing as a key deficit in multiple sclerosis: implications for rehabilitation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Increased activity of hypothalamic corticotropin-releasing hormone neurons in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Heterogeneity of hypothalamic-pituitary-adrenal system response to a combined dexamethasone-CRH test in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Restraint stress suppresses experimental allergic encephalomyelitis in Lewis rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Protective and damaging effects of stress mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Increased Number of Corticotropin-Releasing Hormone Expressing Neurons in the Hypothalamic Paraventricular Nucleus of Patients with Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Cortisol, ACTH, and beta-endorphin after dexamethasone administration in Parkinson's dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Adrenal size is increased in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Adrenal cortical response to stress at Three Mile Island.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

The neuroendocrine axis in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

Neuroendocrine-immune system interactions and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2801%2900071-3

7 January 2021

10.1016/S0306-4530(01)00071-3

Identifiers

DOI

1 reference

28 November 2017

1 reference